Skip to content
GLP-1 Decoder

Liraglutide Fatigue: How Common, How Long It Lasts

Yes. Fatigue is listed in the Saxenda label at 7.5% on Saxenda. Placebo in the Saxenda trials: 4.6%.

Labels that list it
1 of 2
Highest rate
7.5% Saxenda

Saxenda: key facts

How long it remains in the body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours. After 13 h, half is gone, and after five half-lives (2.7 d), about 3% remains.

Weight lost in the main trial
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

The figure reported for SCALE Obesity and Prediabetes, 56 weeks was 7.4% of body weight, versus 3% on placebo.

Sources: FDA label (DailyMed).

How often this shows up with liraglutide compared with placebo

Label trials provide Liraglutide fatigue results for each dose group. Within one trial, placebo is the comparison group.

Fatigue in the liraglutide labels
Medicine and doseFatiguePlaceboMore than placeboPeople in the trials
Saxenda Saxenda7.5%4.6%+2.9 pointsAdults with obesity or overweight (weight management)
Saxenda Saxenda2.1%0.8%+1.3 pointsAdults with obesity or overweight (weight management); the label calls this asthenia
Saxenda Saxenda4.8%3.2%+1.6 pointsChildren 12 and older with obesity

Source: Saxenda label (DailyMed).

Liraglutide Fatigue compared with other GLP-1s

For different groups of people, each label reports separate trials. Treat the results as a rough guide. Read it as a rough guide.

Foundayo pill forms are in the table as well.

Fatigue across GLP-1 labels
MedicineHighest rate in the labelDose groupPlaceboPeople in the trials
Wegovy11%2.4 mg5%Adults with obesity or overweight (weight management)
Foundayo9%17.2 mg4%Adults with obesity or overweight (weight management)
Saxenda7.5%all doses4.6%Adults with obesity or overweight (weight management)
Zepbound7%15 mg3%Adults with obesity or overweight (weight management)
Trulicity5.6%1.5 mg2.6%Adults with type 2 diabetes
Byetta4%all doses2%Adults with type 2 diabetes
OzempicListed, no rate given–––
MounjaroListed, no rate given–––
RybelsusNot listed–––
VictozaNot listed–––

Sources: Wegovy label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Byetta label (DailyMed).

Taken from the FDA label (DailyMed).

Wording in the Saxenda label

Here the label mentions fatigue, word for word:

“Events of asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks of treatment with SAXENDA and were often co-reported with”

Taken from the FDA label (DailyMed).